Tadeja Bevec

435 total citations
8 papers, 362 citations indexed

About

Tadeja Bevec is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Tadeja Bevec has authored 8 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cell Biology and 2 papers in Immunology. Recurrent topics in Tadeja Bevec's work include Calpain Protease Function and Regulation (2 papers), Signaling Pathways in Disease (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Tadeja Bevec is often cited by papers focused on Calpain Protease Function and Regulation (2 papers), Signaling Pathways in Disease (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Tadeja Bevec collaborates with scholars based in Slovenia, Netherlands and Argentina. Tadeja Bevec's co-authors include Brigita Lenar≷cic̆, Vito Türk, Veronika Stoka, Iztok Dolenc, Dirk Bosch, Jože Brzin, I. Kregar, Borut Štrukelj, Kristina Gruden and Tatjana Popović and has published in prestigious journals such as The Journal of Experimental Medicine, FEBS Letters and Immunology.

In The Last Decade

Tadeja Bevec

8 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tadeja Bevec Slovenia	7	196	118	107	53	49	8	362
Ursula Kurzik‐Dumke Germany	13	386 2.0×	94 0.8×	132 1.2×	79 1.5×	105 2.1×	21	603
Robert Kuhelj Slovenia	7	260 1.3×	245 2.1×	60 0.6×	161 3.0×	61 1.2×	9	518
Jean-Pierre Périn France	13	253 1.3×	55 0.5×	52 0.5×	26 0.5×	140 2.9×	17	401
Benjamin Montagne France	8	297 1.5×	30 0.3×	68 0.6×	55 1.0×	34 0.7×	10	387
Barbara Dalie United States	9	302 1.5×	36 0.3×	36 0.3×	62 1.2×	37 0.8×	12	374
Sunandita S. Banerji United States	14	502 2.6×	42 0.4×	50 0.5×	83 1.6×	80 1.6×	17	595
Young-Lan Song South Korea	6	250 1.3×	31 0.3×	156 1.5×	30 0.6×	137 2.8×	7	436
Shih‐Jung Fan United Kingdom	8	353 1.8×	152 1.3×	66 0.6×	21 0.4×	49 1.0×	11	456
Liam T. Seery Ireland	8	226 1.2×	47 0.4×	57 0.5×	122 2.3×	35 0.7×	14	403
Nge Cheong Singapore	16	436 2.2×	148 1.3×	71 0.7×	168 3.2×	40 0.8×	27	734

Countries citing papers authored by Tadeja Bevec

Since Specialization

Citations

This map shows the geographic impact of Tadeja Bevec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadeja Bevec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadeja Bevec more than expected).

Fields of papers citing papers by Tadeja Bevec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadeja Bevec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadeja Bevec. The network helps show where Tadeja Bevec may publish in the future.

Co-authorship network of co-authors of Tadeja Bevec

This figure shows the co-authorship network connecting the top 25 collaborators of Tadeja Bevec. A scholar is included among the top collaborators of Tadeja Bevec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadeja Bevec. Tadeja Bevec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Schweiger, Ana, et al.. (2004). Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes. Immunology. 112(3). 378–385. 15 indexed citations

2.

Dolenc, Iztok, et al.. (2002). Individual Recombinant Thyroglobulin Type-1 Domains Are Substrates for Lysosomal Cysteine Proteinases. Biological Chemistry. 383(11). 1809–12. 7 indexed citations

3.

Kopitar‐Jerala, Nataša, et al.. (2001). Anti-Cathepsin L Monoclonal Antibodies That Distinguish Cathepsin L from Cathepsin V. Biological Chemistry. 382(5). 867–70. 8 indexed citations

4.

Kopitar‐Jerala, Nataša, Tadeja Bevec, Darja Barlič‐Maganja, Franc Gubenšek, & Vito Türk. (2001). Anti-Cathepsin L Monoclonal Antibodies That Distinguish Cathepsin L from Cathepsin V. Biological Chemistry. 382(5). 867–870. 5 indexed citations

5.

Gruden, Kristina, Borut Štrukelj, Tatjana Popović, et al.. (1998). The cysteine protease activity of Colorado potato beetle (Leptinotarsa decemlineata Say) guts, which is insensitive to potato protease inhibitors, is inhibited by thyroglobulin type-1 domain inhibitors. Insect Biochemistry and Molecular Biology. 28(8). 549–560. 64 indexed citations

6.

Lenar≷cic̆, Brigita & Tadeja Bevec. (1998). Thyropins--new structurally related proteinase inhibitors.. PubMed. 379(2). 105–11. 96 indexed citations

7.

Bevec, Tadeja, et al.. (1997). A fragment of the major histocompatibility complex class II – associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi. FEBS Letters. 401(2-3). 259–261. 18 indexed citations

8.

Bevec, Tadeja, et al.. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.. The Journal of Experimental Medicine. 183(4). 1331–1338. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact